Ignite Creation Date:
2024-05-06 @ 6:42 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05753436
Status:
RECRUITING
Last Update Posted:
2024-02-13
First Post:
2023-01-31
Brief Title:
Curcumins Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
Evaluation of the Effect of Curcumin Administration on the Clinical Outcome of Diabetic Patients With Atherosclerotic Cardiovascular Risk
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to assess the safety and efficacy of Curcumin supplementation in combination to the conventional therapy in improving the clinical outcomes oxidative stress and inflammation in diabetic patients with risk of ASCVD
Detailed Description:
Atherosclerotic cardiovascular disease ASCVD is one of the most devastating consequences of Diabetes Mellitus DM especially when combined with other comorbid conditions such as dyslipidemia and hypertension To lessen the probability of ASCVD modifying an individuals lifestyle and regulating ones lipid profile blood pressure and glucose levels are all beneficial approaches that decrease the risk of ASCVD occurrence Numerous diseases including hypertension dyslipidemia and diabetes mellitus have been shown to be significantly influenced by both oxidative stress and inflammation Curcumin is thought to regulate blood pressure lipid profile blood glucose levels Moreover It is claimed that curcumin can alleviate inflammation and oxidative stress Curcumin is therefore suggested to have a beneficial role in lowering the risk of atherosclerotic cardiovascular diseases
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None